Antidepressants Tablets

Drug for bipolar disease^1,2

• Has shown to achieve the clinical response against manic symptoms up to 63%³
• Reduces suicidal risks more than 8-fold¹
• Shows long-term therapeutic response in both typical and a typical features of bipolar disease⁴
• Supports neural plasticity, provides neuroprotection and balances neuronal activities⁵
• Exhibits better efficacy and safety along with faster relief than chlorpromazine6 and olanzapine⁷

FDA approved adjunctive therapy for partial-onset seizures¹

• Third-generation antiepileptic drug that selectively enhances the slow inactivation of voltage-gated sodium channels²
• Possess favourable pharmacokinetic profile with low protein binding and low potential for drug-drug interactions3
• Can be considered as an alternative to Fosphenytoin in the treatment of nonconvulsive seizures (NCS)⁴
• Offers good tolerability and safety for use in status epilepticus (SE)⁵

Details :

• A barbiturate derivative that exhibits potent sedative and anticonvulsant activity²
• Works by acting on GABAA receptors, thereby prolonging the action of GABA¹
• Diminishes excitatory neurotransmission by reducing the effects of glutamate³
• Possesses an inhibitory effect on adult brain' and act as a non-selective central nervous system depressant⁴